T-Cell Non-Hodgkin Lymphoma — Trials

T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,008 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 127
Ph III recruiting: 9
Growth YoY: +23.4%
Industry share: 21%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 301–350 of 519 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00865969	Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma(PTCL)	completed	Phase 2	129	Spectrum Pharmaceuticals, IncINDUSTRY	17	Oct 29, 2021	clinicaltrials
NCT05059912	CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma	unknown	Phase 2	20	The First Affiliated Hospital of Soochow UniversityOTHER	1	Sep 28, 2021	clinicaltrials